A 32-year-old multigravida at 40 weeks with a favorable cervix (Bishop score 8) and intact membranes requires labor induction for post-term pregnancy. Which feature best distinguishes oxytocin from dinoprostone (PGE₂) for labor induction in this clinical scenario?

Explanation

## Pharmacokinetic Distinction: The Best Discriminator in This Clinical Scenario **Key Point:** The most clinically accurate and pharmacologically sound feature distinguishing oxytocin from dinoprostone (PGE₂) is their markedly different onset, offset, and duration of action — oxytocin has a rapid onset and short half-life, while dinoprostone has prolonged systemic effects lasting 12–24 hours. ### Why Option A is Incorrect Option A states that oxytocin acts via **V₁ (vasopressin-1) receptors** — this is a significant factual error. Oxytocin binds to specific **oxytocin receptors (OTR)**, which are G-protein coupled receptors (Gq) distinct from vasopressin V₁ receptors. While oxytocin and vasopressin share structural homology and can cross-react at high concentrations, the primary receptor mediating uterine contraction is the **oxytocin receptor (OTR)**, not V₁. This error in option A makes it pharmacologically inaccurate and therefore not the best answer. *(KD Tripathi, Essentials of Medical Pharmacology, 8th ed.; Goodman & Gilman's Pharmacological Basis of Therapeutics)* ### Oxytocin — Pharmacokinetics - Binds to **oxytocin receptors (OTR)** on myometrial smooth muscle - **Rapid onset:** uterine response within 2–3 minutes of IV infusion - **Short half-life:** 3–5 minutes - **Rapidly reversible:** effects cease quickly upon stopping infusion - Allows precise titration — ideal when cervix is already favorable (Bishop score ≥ 6) - Can be used with intact membranes ### Dinoprostone (PGE₂, Cervidil/Propess) — Pharmacokinetics - Binds to **EP₃ prostaglandin receptors** on myometrial smooth muscle and cervical stroma - **Slower onset:** 30 minutes to several hours - **Prolonged systemic effects:** 12–24 hours after administration - Effects persist even after removal of vaginal insert - Primarily used for **cervical ripening** in unfavorable cervices ## Comparative Table | Feature | Oxytocin | Dinoprostone | |---|---|---| | **Receptor** | Oxytocin receptor (OTR) | EP₃ prostaglandin receptor | | **Onset** | 2–3 minutes | 30 min–several hours | | **Half-life** | 3–5 minutes | 12–24 hours (systemic) | | **Reversibility** | Immediate (stop infusion) | Delayed (prolonged effect) | | **Preferred cervix** | Favorable (Bishop ≥ 6) | Unfavorable (Bishop < 6) | | **Side effects** | Water intoxication, hyponatremia | Fever, diarrhea, bronchospasm | **Clinical Pearl:** In this scenario — a multigravida with a **favorable cervix (Bishop score 8)** — oxytocin is the agent of choice. Its rapid onset and short half-life allow precise titration and immediate reversal if hyperstimulation occurs. Dinoprostone's prolonged 12–24 hour systemic effects make it less controllable and more appropriate for cervical ripening in unfavorable cervices. **High-Yield:** The pharmacokinetic contrast (rapid/titratable oxytocin vs. prolonged/sustained dinoprostone) is the most testable and clinically relevant distinguishing feature for NEET PG / INI-CET. *(Williams Obstetrics, 25th ed.; KD Tripathi, 8th ed.)*